Major drugmakers and top agencies alike earned their flowers at the annual Fierce Pharma Marketing Awards gala in ...
the curiosity to learn, the willingness to adapt, the courage to be uncomfortable, and the commitment to solve real human problems will define the true technology change-makers ...
GSK is acquiring global rights to a T cell engager that Chimagen Biosciences developed to hit three targets. GSK believes this tri-specific approach could offer advantages over currently available ...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often ...
Gallo pulled Golden State Killer after Venice offered it out-of-competition status, with Barbera saying it was the film’s “provocative” content that kept GSK from Golden Lion consideration, which ...
Hansoh Pharmaceutical has guided its GSK-partnered, B7-H3-directed antibody-drug conjugate (ADC) to another phase 3 win in China. Weeks after reporting a victory in small-cell lung cancer (SCLC), ...
GSK GSK-1.07%decrease; down pointing triangle shares fell after the U.K. drugmaker said it would stop working on an experimental treatment for chronic cough that showed limited efficacy in late-stage ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — GSK said Tuesday it would ...
U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based specialist oncology biotech Nuvalent for $10.6 billion. The acquisition could help GSK offset a drop in revenue expected ...
June 8 (Reuters) - UK pharmaceutical group GSK (GSK.L), opens new tab is in talks to buy cancer drugmaker Nuvalent (NUVL.O), opens new tab ‌for more than $9 billion, the Financial Times reported on ...